US Stocks
/
Abeona Therapeutics Inc. Share Price

Abeona Therapeutics Inc. Share Price

NASDAQ: ABEO | Small Cap
$5.93
-$0.12 (-1.9%) Last updated on 29 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Abeona Therapeutics Inc. Stock Performance

Open
$5.93
Prev. Close
$6.04
Circuit Range
N/A
Day Range
$5.88 - $5.98
Year Range
$4.00 - $7.62
Volume
42,782
Average Traded
$5.93

Abeona Therapeutics Inc. Share Price Today

As of 29 August 2026, Abeona Therapeutics Inc.'s share price is $5.93. The stock opened at $5.93, compared to its previous close of $6.04. During today's trading session, Abeona Therapeutics Inc.'s share price traded between $5.88 and $5.98, with an average price of $5.93. Over the past 52 weeks, the stock has recorded a high of $7.62 and a low of $4.00. In terms of performance, Abeona Therapeutics Inc.'s share price has risen by 15.59% over the last six months and is down 13.18% on a year-on-year basis.

Abeona Therapeutics Inc. Share Price Chart

$5.88$5.98
L
Show Current Price
H

Abeona Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$314.01M
PE Ratio (TTM)
4.43
Dividend Yield
N/A
EPS (TTM)
$1.34
Revenue (TTM)
$5.82M
Return On Equity (TTM)
44.71%
Profit Margin
1223.08%
Debt to Equity
0.19
Quarterly Earnings Growth YoY
1369.52%

Abeona Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025
RevenueN/AN/AN/AN/A$400000.00
Net Profit-$31.58M$7.41M-$30.27M-$12.03M$108.83M
Net Profit MarginN/AN/AN/AN/A27208.25%
Income ChangeN/A123.45%-508.71%60.26%1004.76%

Abeona Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$3.50MN/A$5.82M
Net Profit-$54.19M-$63.73M$71.18M
Net Profit Margin-1548.23%N/A1223.08%
Income ChangeN/A-17.62%211.69%

About Abeona Therapeutics Inc.

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.

Abeona Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$6.34
$6.05
-5.91%
Jul 2026
$6.29
$6.43
+4.47%
Jun 2026
$5.64
$6.16
+6.12%
May 2026
$5.46
$5.80
+6.52%
Apr 2026
$4.51
$5.45
+21.27%
Mar 2026
$5.09
$4.49
-12.48%
Feb 2026
$5.05
$5.13
+0.79%
Jan 2026
$5.22
$5.09
-3.51%
Dec 2025
$4.98
$5.28
+4.25%
Nov 2025
$4.75
$5.06
+5.31%
Oct 2025
$5.26
$4.80
-8.91%
Sep 2025
$6.92
$5.28
-22.77%

ABEO Share Price FAQs

What is Abeona Therapeutics Inc. share price today?

chevron-up
Abeona Therapeutics Inc. share price today is $5.93 as on August 29, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Abeona Therapeutics Inc. stock?

chevron-up
The 52 week high of Abeona Therapeutics Inc. stock is $7.62, while the 52 week low is $4.00 as of 29 Aug '26.

What is ABEO's market capitalisation today?

chevron-up
ABEO market capitalisation is $314.01M as of August 29, 2026, at 2:30 pm IST.

What is ABEO's net income for the last quarter?

chevron-up
ABEO's net income for the last quarter is 0.11B USD.

What is the 5 year returns of ABEO?

chevron-up
The 5 year returns of ABEO is -82.10% as on 29 Aug '26.

What is the high & low stock price of ABEO today?

chevron-up
ABEO stock price hit a high of $5.98 and low of $5.88 as of 29 Aug '26.

Can I buy ABEO shares in India?

chevron-up
Yes. You can buy ABEO in India by opening an international trading account.